Cervical cancer is a medical abnormality in which cells of the inside layer of cervix slowly become a bunch of pre-cancerous cells, thereby leading to the formation of cancerous tumors. Tests done to diagnose cervical cancer are known as cervical cancer diagnostics tests.
Such tests are called pap smear tests. The cervical cancer diagnostics tests market was worth about USD 28 million in 2011. It is projected to develop from 2012 to 2018, at a CAGR of around 1.5 percent and is likely to attain around USD 31 million in 2018.
The United States of America dominates the worldwide cervical cancer diagnostics tests market. It accounts for a share of about 31 percent.